Computationally prioritized drugs inhibit SARS-CoV-2 infection and syncytia formation

The pharmacological arsenal against the COVID-19 pandemic is largely based on generic anti-inflammatory strategies or poorly scalable solutions. Moreover, as the ongoing vaccination campaign is rolling slower than wished, affordable and effective therapeutics are needed. To this end, there is increa...

Descripción completa

Detalles Bibliográficos
Autores principales: Serra, Angela, Fratello, Michele, Federico, Antonio, Ojha, Ravi, Provenzani, Riccardo, Tasnadi, Ervin, Cattelani, Luca, del Giudice, Giusy, Kinaret, Pia A S, Saarimäki, Laura A, Pavel, Alisa, Kuivanen, Suvi, Cerullo, Vincenzo, Vapalahti, Olli, Horvath, Peter, Lieto, Antonio Di, Yli-Kauhaluoma, Jari, Balistreri, Giuseppe, Greco, Dario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Case Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769897/
https://www.ncbi.nlm.nih.gov/pubmed/34962256
http://dx.doi.org/10.1093/bib/bbab507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769897/
https://www.ncbi.nlm.nih.gov/pubmed/34962256
http://dx.doi.org/10.1093/bib/bbab507

Ejemplares similares